Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party

  • Hélène Schoemans
  • Linda J. Burns
  • Sarah J. Liptrott
  • John Murray
  • Michelle Kenyon
  • Anna Barata
  • Natacha Bolaños
  • Isabelle Scholl
  • Betty Hamilton
  • Rachel Phelan
  • David Buchbinder
  • Olaf Penack
  • Ivan Moiseev
  • William Boreland
  • Christophe Peczynski
  • Sabina De Geest
  • Anna Sureda
  • John A. Snowden
  • Bronwen Shaw
  • Zinaida Peric
  • Nicolaus Kroeger

Abstract

The EBMT (European Blood and Marrow Transplantation Society) aims to connect patients, the scientific community, and other stakeholders to improve hematopoietic stem cell transplantation and cellular therapy outcomes. We performed a cross-sectional online survey to understand the perceptions regarding Patient Reported Outcomes (PROs) and Patient Active Involvement in Research (PAIR) in over 800 stakeholders (n = 813). Patients (n = 278) and health care professionals (HCPs) (n = 351) were compared. We observed high openness for EBMT PRO collection (n = 680, 84.5% across stakeholders’ groups; patients n = 256, 93.1% versus HCPs n = 273, 78.4% [p 

Bibliographical data

Original languageEnglish
ISSN1476-5365
DOIs
Publication statusPublished - 09.2024